TAZAROTENE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 33 adverse event reports in the FDA FAERS database where TAZAROTENE was used for Psoriasis.
Most Reported Side Effects for TAZAROTENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 61 | 14.3% | 0 | 0 |
| Off label use | 54 | 12.6% | 0 | 0 |
| Application site erythema | 50 | 11.7% | 0 | 0 |
| Skin exfoliation | 49 | 11.5% | 0 | 2 |
| Erythema | 46 | 10.8% | 0 | 0 |
| Application site pain | 40 | 9.4% | 0 | 0 |
| Rash | 33 | 7.7% | 0 | 0 |
| Application site exfoliation | 24 | 5.6% | 0 | 0 |
| Pruritus | 22 | 5.1% | 0 | 0 |
| Application site discolouration | 19 | 4.4% | 0 | 0 |
| Burning sensation | 18 | 4.2% | 0 | 0 |
| Dry skin | 18 | 4.2% | 0 | 0 |
| Pain | 18 | 4.2% | 0 | 0 |
| Application site dryness | 16 | 3.7% | 0 | 0 |
| Application site pruritus | 16 | 3.7% | 0 | 0 |
Other Indications for TAZAROTENE
Acne (165)
Product used for unknown indication (138)
Metastatic malignant melanoma (11)
Skin wrinkling (9)
Rash (6)
Acne cystic (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)